Advanced Bronchodilator, Mucolytic & Expectorant
A powerhouse triple-action respiratory suspension combining the bronchodilating effects of Levosalbutamol, the mucolytic action of Ambroxol, and the expectorant properties of Guaiphenesin. Formulated into a highly stable liquid carrier base with Sunset Yellow FCF integration. Carefully optimized to clear thick obstructive mucus pathways, relieve bronchospasm, and ease chest congestion in pediatric patients.
Levosalbutamol relaxes airways to ease respiratory strain.
Ambroxol breaks down deep-seated, stubborn bronchial secretions.
Guaiphenesin promotes expectoration to fully clear pathways.
Each 5 mL volume unit of the suspension contains the following active metrics:
| Active Components | Quantitative Standard Value |
|---|---|
| Levosalbutamol Sulphate IP | 1 mg |
| Ambroxol Hydrochloride IP | 30 mg |
| Guaiphenesin IP | 50 mg |
| Excipients | q.s. |
| Colour Carrier integration | Sunset Yellow FCF |
Launch your brand variation without restrictive capital layout barriers.
Manufactured using highly certified strict regulatory laboratory controls.
Highly optimized automated synthesis runs to guarantee low unit costs.
Full-scale workflow integration, spanning master formula creation down to compliance log tracking.
Dosage Parameters: Administer precise volumetric parameters orally as directed by a practicing Physician.
Storage Protocols: Keep locked inside cool, dry, and dark environments. Protect from exposure to structural light grids. Shake the suspension cleanly before each use. Keep medicine out of reach of children.
